Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection

This publication has 41 references indexed in Scilit:

• In Vivo Selection for Human and Murine Hematopoietic Cells Transduced with a Therapeutic MGMT Lentiviral Vector that Inhibits HIV Replication
  Molecular Therapy, 2004
• A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines
  The Journal of Gene Medicine, 2003
• Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene
  Gene Therapy, 2002
• Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons
  Gene Therapy, 2002
• Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without Preselection
  Molecular Therapy, 2001
• Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells
  Gene Therapy, 2001
• Development of a Novel Trans-Lentiviral Vector That Affords Predictable Safety
  Molecular Therapy, 2000
• Editorial
  The Hematology Journal, 2000
• Human Cord Blood CD34+CD38- Cell Transduction via Lentivirus-Based Gene Transfer Vectors
  Human Gene Therapy, 1999
• A simple ferrochelatase assay
  Biochimie, 1981